Greek Health Minister to Speak in London About Greece's Groundbreaking Medical Cannabis Programme

April 11, 2024 08:30 PM AEST | By EIN Presswire
 Greek Health Minister to Speak in London About Greece's Groundbreaking Medical Cannabis Programme
Image source: EIN Presswire
LONDON, UNITED KINGDOM, April 11, 2024 /EINPresswire.com/ -- Greek Health Minister to speak at Cannabis Europa London on Greece’s groundbreaking new medical cannabis programme, joined by Curaleaf executive chairman, Boris Jordan, and former Wimbledon champion, Pat Cash.

Cannabis Europa, the premier conference for the emerging European cannabis industry, is thrilled to announce its lineup of headline speakers for the 2024 edition.

Set to take place from June 25-26 at the Barbican Centre in London, this year's conference and expo promises to be a groundbreaking exploration of the latest regulatory advancements and investment opportunities in this burgeoning sector. This year's headline speakers for Cannabis Europa London include.

Adonis Georgiadis, Greek Minister for Health: As the Greek Health Minister, Adonis Georgiadis has been instrumental in spearheading the latest cannabis regulatory initiatives in Greece; where 60 year old Anna Paga recently became one of the first ever medical cannabis patients to receive a prescription in the country.

Boris Jordan, Executive Chairman at Curaleaf: The visionary behind Curaleaf, one of the largest and most successful cannabis companies globally, brings unparalleled expertise to Cannabis Europa 2024 as a preeminent leader in the sector. With a proven track record of driving innovation and growth in the industry, Jordan's insights will be invaluable for those seeking to understand the future trajectory of medical cannabis and its impact on global markets.

Pat Cash, Former Wimbledon Champion: Beyond the realm of sports, Pat Cash has become a vocal advocate for the medicinal applications of cannabis. Cash's presence underscores the growing acceptance of cannabis as a legitimate medical treatment and promises to spark engaging discussions on its potential benefits, especially in the realm of sports recovery.

You can see the full line-up of speakers for Cannabis Europa 2024 here, offering attendees a unique opportunity to engage with industry leaders, policymakers, investors, and experts from around the world. From networking with potential investors to gaining insights into regulatory frameworks, the conference provides a comprehensive platform for individuals and organisations looking to enter the burgeoning medical cannabis industry or drive their own operation forward.

“The European cannabis sector is experiencing dynamic growth and regulatory evolution, with increasing acceptance and legalisation driving opportunities in medical, wellness, and recreational markets, yet it faces challenges in harmonising regulations across different countries” - Adonis Georgiadis, Greek Minister for Health

“The passage of the Cannabis Act in Germany represents a watershed moment for patients and future adult-use consumers alike. This legislation has set the standard for future cannabis regulatory programs across all of Europe and serves as a wakeup call to U.S. politicians and our regulatory agencies, who continue to stall progress. Curaleaf’s significant investment over three years, established cultivation infrastructure in Portugal, patient platform and complete brand portfolio, ensures we are ready to capitalise on the massive opportunity in Europe.” - Boris Jordan, Curaleaf

Don't miss your chance to be part of the conversation at Cannabis Europa 2024. Register now to secure your place at the forefront of the medical cannabis revolution. For more information and to register, visit: https://cannabis-europa.com

About Cannabis Europa:

Cannabis Europa is the leading conference series focused on shaping the future of medical cannabis in Europe. Through cutting-edge discussions, expert insights, and networking opportunities, Cannabis Europa brings together industry leaders, policymakers, investors, and healthcare professionals to drive innovation and progress in the medical cannabis Sector.

Matt Freemantle
Cannabis Europa
+34 645116528
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.